Dr Lulu Bravo : A New Dengue Vaccine
4.8 (502) · $ 17.99 · In stock
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial - ScienceDirect
Facebook and Instagram campaign using behavioural science drove more than 6 million people closer to COVID-19 jabs
TropicalMed Special Issue : Recent Advances in Dengue
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults
Making Vaccines About Science, Not Politics - Asian Scientist Magazine
Efficacy of a Cell-Culture–Derived Quadrivalent Influenza Vaccine in Children
Economic Cost and Burden of Dengue in the Philippines in: The American Journal of Tropical Medicine and Hygiene Volume 92 Issue 2 (2015)
Seth Toback, MD, MMM on LinkedIn: #covid #vaccines #novavax
Pediatric Oncall
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination. - Abstract - Europe PMC
